$7.52 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$84.38 - $220.20The lowest and highst price in the last 52 weeks.
16.84xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$0.00 (0.0%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$7.52 Billion|
|Enterprise Value||$4.93 Billion|
|Dividend Yield||$0.00 (0.0%)|
|1 Year Return||-2.6%|
|Outstanding Shares||76.2 Million|
|Avg 30 Day Volume||1.6 Million|
|Earnings per Share||$6.01|
|Price to Sales Ratio||8.75|
|Price to Book Ratio||2.83|
|Revenue to Enterprise Value||5.47|
|EBIT to Enterprise Value||11.01|
|Total Debt to Enterprise Value||0.0|
|Debt to Equity||0.0|
|Gross Profit||$902 Million|
|Net Income||$447 Million|
|Quarterly Earnings Growth (YoY)||-1053.1%|
|Return on Equity||17.15%|
|Return on Assets||15.4%|
|Return on Invested Capital||16.0%|
12,437 shares sold (3 transactions)
89,304 shares sold (7 transactions)
22,515 shares sold (2 transactions)
CEO: Samarth Kulkarni
Industry: Biological Product (except Diagnostic) Manufacturing
Shares of CRISPR Therapeutics AG (NASDAQ: CRSP ) may be forming a V bottom on the chart. That means the stock could rally. V bottoms and V tops illustrate rapid reversals of a trend. A characterist...Benzinga, 5 days ago
No summary available.Seeking Alpha, 6 days ago
The post RBC Capital sees upside to $117 appeared on BitcoinEthereumNews.com . Shares of CRISPR Therapeutics AG (NASDAQ: CRSP) fell just under 10% on Wednesday as the biotech firm presented updated...Bitcoin Ethereum News, 6 days ago